• 1
    Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005; 17: 8992.
  • 2
    Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs 2007; 67: 18031812.
  • 3
    Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008; 14 (Suppl 4): 524.
  • 4
    Kubak BM, Pegues DA, Holt CD, Hwang AH. Changing patterns of fungal infection in transplantation. Curr Opin Organ Transplant 2000; 5: 176191.
  • 5
    Varkey JB, Perfect JR. Rare and emerging fungal pulmonary infections. Semin Respir Crit Care Med 2008; 29: 121131.
  • 6
    Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519531.
  • 7
    Stelzmueller I, Lass-Floerl C, Geltner C et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int 2008; 21: 534546.
  • 8
    Husain S, Alexander BD, Munoz P et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221229.
  • 9
    Fungal infections. Am J Transplant 2004; 4 (Suppl 10): 110134.
  • 10
    Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70: 112116.
  • 11
    Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis 2001; 3: 128137.
  • 12
    Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16: 915933, vi-vii.
  • 13
    Sole A, Salavert M. Fungal infections after lung transplantation. Transplant Rev (Orlando) 2008; 22: 89104.
  • 14
    Symoens F, Knoop C, Schrooyen M et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25: 603607.
  • 15
    Gauwerky K, Borelli C, Korting HC. Targeting virulence: A new paradigm for antifungals. Drug Discov Today 2009.
  • 16
    Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006; 20: 581607, vi.
  • 17
    Siwek GT, Dodgson KJ, De Magalhaes-Silverman M et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584587.
  • 18
    Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950952.
  • 19
    Murray PR, American Society for Microbiology. Manual of clinical microbiology. 7th ed. Washington , D.C. : ASM Press, 1999.
  • 20
    Crissey JT, Lang H, Parish LC. Manual of medical mycology. Cambridge , Mass , USA : Blackwell Scientific, 1995.
  • 21
    Patterson TF. Advances and challenges in management of invasive mycoses. Lancet 2005; 366: 10131025.
  • 22
    Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009; 47: 315.
  • 23
    Logan PM, Primack SL, Miller RR, Muller NL. Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. Radiology 1994; 193: 383388.
  • 24
    Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 5356.
  • 25
    Kanj SS, Welty-Wolf K, Madden J et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) 1996; 75: 142156.
  • 26
    Nunley DR, Gal AA, Vega JD, Perlino C, Smith P, Lawrence EC. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002; 122: 11851191.
  • 27
    Paradowski LJ. Saprophytic fungal infections and lung transplantation–revisited. J Heart Lung Transplant 1997; 16: 524531.
  • 28
    Silveira FP, Kwak EJ, Paterson DL, Pilewski JM, McCurry KR, Husain S. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008; 27: 850855.
  • 29
    Sahi H, Avery RK, Minai OA et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007; 26: 350356.
  • 30
    Rubin RH, Young LS. Clinical approach to infection in the compromised host. 4th ed. New York : Kluwer Academic/Plenum, 2002.
  • 31
    Gill J, Madhira BR, Gjertson D et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 2008; 3: 18201828.
  • 32
    Wuyts WA, Molzahn H, Maertens J et al. Fatal Scopulariopsis infection in a lung transplant recipient: a case report. J Heart Lung Transplant 2005; 24: 23012304.
  • 33
    Castelli MV, Buitrago MJ, Bernal-Martinez L, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J Clin Microbiol 2008; 46: 34123416.
  • 34
    Spiess B, Seifarth W, Hummel M et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 37433753.
  • 35
    Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006; 6: 23652374.
  • 36
    Abbott KC, Hypolite I, Poropatich RK et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001; 3: 203211.
  • 37
    Einollahi B, Taheri S. Renal transplantation practice in Iran and the Middle East: report from Iran and a review of the literature. Ann Transplant 2008; 13: 514.
  • 38
    Jimenez C, Lumbreras C, Paseiro G et al. Treatment of mucor infection after liver or pancreas-kidney transplantation. Transplant Proc 2002; 34: 8283.
  • 39
    Dubey A, Patwardhan RV, Sampth S, Santosh V, Kolluri S, Nanda A. Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol 2005; 63: 254260; discussion 260.
  • 40
    Uckay I, Chalandon Y, Sartoretti P et al. Invasive zygomycosis in transplant recipients. Clin Transplant 2007; 21: 577582.
  • 41
    Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008; 10: 419425.
  • 42
    McGuire FR, Grinnan DC, Robbins M. Mucormycosis of the bronchial anastomosis: a case of successful medical treatment and historic review. J Heart Lung Transplant 2007; 26: 857861.
  • 43
    Forrest GN, Mankes K. Outcomes of invasive zygomycosis infections in renal transplant recipients. Transpl Infect Dis 2007; 9: 161164.
  • 44
    Marks WH, Florence L, Lieberman J et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996; 61: 17711774.
  • 45
    Mattner F, Weissbrodt H, Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004; 36: 312314.
  • 46
    Husain S, Munoz P, Forrest G et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 8999.
  • 47
    Rodriguez-Tudela JL, Berenguer J, Guarro J et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2008: 112.
  • 48
    Musk M, Chambers D, Chin W, Murray R, Gabbay E. Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant 2006; 25: 12681272.
  • 49
    Farina C, Gotti E, Suter F, Goglio A. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature. Transplant Proc 2006; 38: 13331335.
  • 50
    Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005; 139: 370373.
  • 51
    Rogasi PG, Zanazzi M, Nocentini J et al. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Transplant Proc 2007; 39: 20332035.
  • 52
    Ahmed J, Ditmars DM, Sheppard T, Del Busto R, Venkat KK, Parasuraman R. Recurrence of Scedosporium apiospermum infection following renal re-transplantation. Am J Transplant 2004; 4: 17201724.
  • 53
    Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987; 106: 209216.
  • 54
    Brown RS Jr, Lake JR, Katzman BA et al. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation 1996; 61: 666669.
  • 55
    Schell WA. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med 1995; 15: 365387.
  • 56
    Kibbler CC. Infections in liver transplantation: risk factors and strategies for prevention. J Hosp Infect 1995; 30 (Suppl): 209217.
  • 57
    Goldfarb NS, Avery RK, Goormastic M et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71: 242246.
  • 58
    Kriett JM, Smith CM, Hayden AM et al. Lung transplantation without the use of antilymphocyte antibody preparations. J Heart Lung Transplant 1993; 12 (6 Pt 1): 915922; discussion 922–913.
  • 59
    Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006; 12: 948960.
  • 60
    Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008; 10: 117122.
  • 61
    Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002; 35: 13601367.
  • 62
    De Miguel D, Gomez P, Gonzalez R et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005; 53: 3337.
  • 63
    Bowden RA, Ljungman P, Paya CV. Transplant infections. 2nd ed. Philadelphia : Lippincott Williams & Wilkins, 2003.
  • 64
    Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1: 247261.
  • 65
    Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997; 24: 369374.
  • 66
    Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910913.
  • 67
    McCown HF, Sahn EE. Subcutaneous phaeohyphomycosis and nocardiosis in a kidney transplant patient. J Am Acad Dermatol 1997; 36 (5 Pt 2): 863866.
  • 68
    Parra IH, Galimberti R, Galimberti G, Guanella B, Kowalczuk A. Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient. Int J Dermatol 2008; 47: 571574.
  • 69
    Sartoris KE, Baillie GM, Tiernan R, Rajagopalan PR. Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: case report and review of the literature. Pharmacotherapy 1999; 19: 9951001.
  • 70
    Calabro G, Nino M, Gallo L, Scalvenzi M. Cutaneous alternariosis in a kidney transplantation recipient: report of a case. J Dermatolog Treat 2008; 19: 246248.
  • 71
    Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002; 3: 1935.
  • 72
    Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677688.
  • 73
    Lussier N, Laverdiere M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis 2000; 31: 12991301.
  • 74
    Netsvyetayeva I, Swoboda-Kopec E, Sikora M, Jaworska-Zaremba M, Blachnio S, Luczak M. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses 2008.
  • 75
    Ness MJ, Markin RS, Wood RP, Shaw BW Jr, Woods GL. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol 1989; 92: 119123.
  • 76
    Finkelstein R, Singer P, Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med 1989; 86: 133.
  • 77
    Abdala E, Lopes RI, Chaves CN, Heins-Vaccari EM, Shikanai-Yasuda MA. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl Infect Dis 2005; 7: 162165.
  • 78
    Nettles RE, Nichols LS, Bell-McGuinn K, Pipeling MR, Scheel PJ Jr, Merz WG. Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient. Clin Infect Dis 2003; 36: E6366.
  • 79
    Madhavan T, Eisses J, Quinn EL. Infections due to Trichosporon cutaneum, an uncommon systemic pathogen. Henry Ford Hosp Med J 1976; 24: 2730.
  • 80
    Saul SH, Khachatoorian T, Poorsattar A et al. Opportunistic Trichosporon pneumonia. Association with invasive aspergillosis. Arch Pathol Lab Med 1981; 105: 456459.
  • 81
    Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983; 198: 622629.
  • 82
    Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006; 42: 753757.
  • 83
    Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 2000; 19: 215219.
  • 84
    Ertam I, Aytimur D, Alper S. Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient. Indian J Dermatol Venereol Leprol 2007; 73: 425426.
  • 85
    Zhao HM, Ran YP, Jiang X et al. [Isolation of Malassezia furfur from the groin abscess of a renal transplant patient]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005; 36: 143146.
  • 86
    Alothman A. Rhodotorula species peritonitis in a liver transplant recipient: a case report. Saudi J Kidney Dis Transpl 2006; 17: 4749.
  • 87
    Riedel DJ, Johnson JK, Forrest GN. Rhodotorula glutinis fungemia in a liver-kidney transplant patient. Transpl Infect Dis 2008; 10: 197200.
  • 88
    Gamma R, Carrel T, Schmidli J et al. Transplantation of yeast-infected cardiac allografts: a report of 2 cases. J Heart Lung Transplant 2005; 24: 11591162.
  • 89
    Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol 2003; 41: 52335235.
  • 90
    Qadri SM, Al Dayel F, Strampfer MJ, Cunha BA. Urinary tract infection caused by Hansenula anomala. Mycopathologia 1988; 104: 99101.
  • 91
    Wang JL, Hung CC, Chang SC, Chueh SC, La MK. Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B. Transplantation 2003; 76: 11361137.
  • 92
    Hung CC, Hsueh PR, Chen MY, Hsiao CH, Chang SC, Luh KT. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis 1998; 26: 202203.
  • 93
    Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc 1999; 50: 111114.
  • 94
    Chan YH, Wong KM, Lee KC et al. Pneumonia and mesenteric lymphadenopathy caused by disseminated Penicillium marneffei infection in a cadaveric renal transplant recipient. Transpl Infect Dis 2004; 6: 2832.
  • 95
    Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis 1984; 129: 340342.
  • 96
    Shikanai-Yasuda MA, Duarte MI, Nunes DF et al. Paracoccidioidomycosis in a renal transplant recipient. J Med Vet Mycol 1995; 33: 411414.
  • 97
    Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop Sao Paulo 2004; 46: 279281.
  • 98
    Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987; 9: 369375.
  • 99
    Tambini R, Farina C, Fiocchi R et al. Possible pathogenic role for Sporothrix cyanescens isolated from a lung lesion in a heart transplant patient. J Med Vet Mycol 1996; 34: 195198.
  • 100
    Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008; 61 (Suppl 1): i35i40.
  • 101
    Frampton JE, Scott LJ. Posaconazole: a review of its use in the prophylaxis of invasive fungal infections. Drugs 2008; 68: 9931016.
  • 102
    Stanzani M, Vianelli N, Bandini G et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006; 53: e243e246.
  • 103
    Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005; 18: 613618.
  • 104
    Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother 2006; 50: 22482250.